-
Top Trending Tickers On StockTwits For February 19
Wednesday, February 19, 2014 - 11:46am | 648Read More...Here's a look at the top tickers trending on StockTwits.com Chelsea Therapeutics: FDA Approval confirmed On Tuesday, shares of Chelsea Therapeutics (NASDAQ: CHTP) were halted. An FDA decision for the company's Northera drug application was postponed from Friday due to severe weather. Shortly...
-
Top Trending Tickers On StockTwits For February 14
Friday, February 14, 2014 - 12:06pm | 902Read More...Here's a look at the top tickers trending on StockTwits.com Tesla: Robust sales in California According to Bloomberg, Tesla Motors' (NASDAQ: TSLA) Model S sedan ranks third place among luxury cars in California in 2013. According to a market report from the California New Car Dealers...
-
Market Wrap For February 12: Markets Take a Breather, Senate Passes Debt Limit Bill
Wednesday, February 12, 2014 - 5:59pm | 3119Read More...U.S. stocks took a breather on Wednesday with major indices little changed after one of the largest four-day bull runs in recent history. The House has authorized a one year extension to the government's borrowing authority until March 16, 2015. The Senate gave the final seal of approval this...
-
Market Wrap For January 15: Bulls Take Over As Economic Growth Remains Healthy
Wednesday, January 15, 2014 - 5:45pm | 2827Read More...The market picked up where it left off Tuesday and recorded a second straight day of strong gains. The Dow posted a triple digit point gain while the S&P 500 and Nasdaq all gained as the Federal Reserve's Beige Book indicated that economic growth remained healthy in most U.S. regions. The...
-
Market Wrap For January 3: Bernanke Speaks As Fed Chairman For Last Time; Markets Little Moved
Friday, January 3, 2014 - 5:29pm | 1497Read More...Fed Chairman Ben Bernanke took to the podium today in what many consider to be his farewell speech. During his tenure, Bernanke developed the nickname "Helicopter Ben," which is likely to stick with him for some time. Bernanke noted, "The FOMC's decision to modestly reduce the pace of asset...
-
Wedbush Maintains Outperform on Chelsea Therapeutics
Tuesday, June 21, 2011 - 7:41am | 107Read More...Wedbush is out with its report today on Chelsea Therapeutics (NASDAQ: CHTP), maintaining Outperform. In a note to clients, Wedbush writes, "We maintain our OUTPERFORM rating and fair value of $8. We believe the recent rise in CHTP resulted from the impact of data presented at ICPDMD and...
-
Wedbush Maintains Outperform on Chelsea Therapeutics
Monday, June 13, 2011 - 7:50am | 106Read More...Wedbush is out with its report today on Chelsea Therapeutics (NASDAQ: CHTP), maintaining Outperform. In a note to clients, Wedbush writes, "We maintain our OUTPERFORM rating and fair value of $8. We believe the rise in CHTP resulted from the impact of data presented at ICPDMD and illustrate the...
-
List of Seven Cheap Biotech Stocks Expected to Grow, Seeking Alpha Reports (CHTP, TLON, HGSI, VNDA, OREX, SNTA, VICL)
Thursday, April 28, 2011 - 3:16pm | 504Read More...Seeking Alpha lists Biotech stocks that are currently very cheap, but are anticipating significant growth in the future. Chelsea Therapeutics (NASDAQ: CHTP) is one to watch, Seeking Alpha explains, “Chelsea Therapeutics (CHTP) is trading around $4. CHTP is a biotechnology company, based in North...
-
Oppenheimer's Current Biotech Ratings
Monday, September 13, 2010 - 10:41am | 138Read More...Stock Prices as of September 10, 2010 Anadys Pharmaceuticals Inc. (NASDAQ: ANDS) $1.75, PERFORM BioMarin Pharmaceutical (NASDAQ: BMRN) $22.62, PERFORM Chelsea Therapeutics (NASDAQ: CHTP) $3.91, PERFORM Dynavax Technologies (NASDAQ: DVAX) $1.69, PERFORM Genzyme (NASDAQ: GENZ) $70.63, PERFORM...
